Furthermore, METTL14 knockdown has been associated with increased tumor immunogenicity, as evidenced by enhanced CD8+ T‐cell infiltration and elevated secretion of IFN‐γ and CXCL9/10 within the tumor microenvironment [30]. The gene discussed is CXCL9; the disease is neoplasm.